Apixaban Versus Aspirin to Reduce Cognitive Decline After Cryptogenic Stroke and Atrial Cardiopathy: ARCADIA‐Cognition Study
- DOI
- 10.1161/jaha.125.042147
- Published
- 2025-09-16
- Container
- Journal of the American Heart Association
- Publisher
- Ovid Technologies (Wolters Kluwer Health)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1161/jaha.125.042147,
title = {Apixaban Versus Aspirin to Reduce Cognitive Decline After Cryptogenic Stroke and Atrial Cardiopathy: ARCADIA‐Cognition Study},
author = {Ronald M. Lazar and George Howard and Michael T. Brewer and Christy Cassarly and Qi Pauls and Stephanie Kemp and David L. Tirschwell and Kevin N. Sheth and Max Wintermark and Hooman Kamel and W. T. Longstreth Jr and Mitchell S.V. Elkind and Joseph P. Broderick and Maarten G. Lansberg},
year = {2025},
journal = {Journal of the American Heart Association},
doi = {10.1161/jaha.125.042147},
url = {https://doi.org/10.1161/jaha.125.042147}
}RIS
TY - JOUR TI - Apixaban Versus Aspirin to Reduce Cognitive Decline After Cryptogenic Stroke and Atrial Cardiopathy: ARCADIA‐Cognition Study AU - Ronald M. Lazar AU - George Howard AU - Michael T. Brewer AU - Christy Cassarly AU - Qi Pauls AU - Stephanie Kemp AU - David L. Tirschwell AU - Kevin N. Sheth AU - Max Wintermark AU - Hooman Kamel AU - W. T. Longstreth Jr AU - Mitchell S.V. Elkind AU - Joseph P. Broderick AU - Maarten G. Lansberg PY - 2025 JO - Journal of the American Heart Association DO - 10.1161/jaha.125.042147 UR - https://doi.org/10.1161/jaha.125.042147 ER -
APA
Lazar, R. M., Howard, G., Brewer, M. T., Cassarly, C., Pauls, Q., Kemp, S., Tirschwell, D. L., Sheth, K. N., Wintermark, M., Kamel, H., Jr, W. T. L., Elkind, M. S., Broderick, J. P., & Lansberg, M. G. (2025). Apixaban Versus Aspirin to Reduce Cognitive Decline After Cryptogenic Stroke and Atrial Cardiopathy: ARCADIA‐Cognition Study. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.042147
Source records
- crossref · retrieved 2026-09-26T19:35:27.107Z